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Summary
Histamine and tumor necrosis factor cx (TNF-a) can each contribute to the pathogenesis of allergic
reactions and chronic inflammatory diseases. We now report the effect of histamine on gene
expression and total cellular synthesis of TNF-cx. Lipopolysaccharide (LPS)-induced synthesis
ofTNF-cx in peripheral blood mononuclear cells (PBMC) from 18 healthy donors was suppressed
by histamine concentrations from 10 -6 to 10 -4 M, levels comparable with those measured in
tissues after mast cell degranulation. Histamine (10 -5 M) markedly suppressed LPS-induced
synthesis of TNF-ce in both unfractionated PBMC (83% inhibition, p < 0.001) and monocytes
purified by positive selection of LeuM3+ cells (62% inhibition, p < 0.05). The suppressive effect
ofhistamine on TNF-ci synthesis did not require the presence ofT cells. The histamine-mediated
decrease in TNF-(x synthesis was not affected by indomethacin, nor by diphenhydramine, an
Hl receptor antagonist, but was reversed by cimetidine or ranitidine, H2 receptor antagonists,
in a dose-dependent manner. Suppression of TNF-cx synthesis by histamine is likely to be a
transcriptional event, since histamine (10-5 M) reduced TNF-a mRNA levels fourfold. These
results suggest that histamine release from mast cells may paradoxically limit the extent of
inflammatory and immune reactions by suppressing local cytokine synthesis in H2 receptor-
bearing cells.
istamine is released from basophils and mast cells during
immediate-type hypersensitivity reactions. Histamine
Hl receptors mediate many of the inflammatory effects of
histamine, whereas H2 receptors mediate various immuno-
regulatory effects. In the latter case, histamine inhibits sev-
eral lymphocyte functions (1) and reduces the production of
lymphokines, including macrophage migration-inhibitory
factor (MIF) (1), leukocyte migration-inhibitory factor (LIF)
(1), IIr2, and IFN-y (2). Histamine also inhibits the produc-
tion of 11.4-like activity by LPS-stimulated human mono-
cytes (3) .
TNF-cx, also named cachectin, displays a multitude of
inflammatory and immunological functions (4). Recently,
TNF-ce has been shown to contribute to the mast cell-de-
pendent recruitment ofleukocytes during the IgE-dependent
cutaneous late phase reactions (5). We .investigated whether
histamine could modulate the synthesisof TNF-a. Modula-
tion by histamine of gene expression and total cellular syn-
thesis of TNF-a were studied in human PBMC and purified
monocytes stimulated with LPS.
Materials and Methods
HumanPBMC Cultum
￿
PBMC were separated from heparinized
blood as described previously (6). PBMC (2.5 x 106 cells/ml in
RPMI added with 1% heat-inactivated human AB serum) were
stimulatedwith LPS from Escherichia coli 055:B5 (10 ng/ml; Sigma
Chemical Co., St. Louis, MO) in the presence or absence ofhista-
mine (Sigma Chemical Co.) for 24 h at 37°C in a humidified at-
mosphere containing 5% C02. Cell cultures were then assayed for
total (cell-associated + secreted) TNF-a synthesis using a specific
RIA (7). The sensitivities (defined as 95% binding) of RIAs for
TNF-ce were 71 ± 6 pg/ml (n = 12).
In other experiments, PBMC (5 x 106 cells/ml) were prein-
cubated for 1 h at 37'C in the presence of either indomethacin
(1.3 x 10 -6 M; Sigma Chemical Co.), diphenhydramine (10- s M;
Elkins-Sinn, Inc., Cherry Hill, NJ), cimetidine (10-6 to 10 -° M;
Smith Kline & French, Philadelphia, PA), ranitidine (10-e
M; Glaxo, Inc., Research Triangle Park, NC), or RPMI.
HistamineRIA.
￿
PBMC supernatants were assayed for secreted
histamine by specific RIA. The limit of detection was 3 ng/ml (1.6
x 10- e M). Crossreactivity studies showed negligible reactivity
(40.5%) with r,-histidine, spermidine, or serotonin.
Isolation ofLeuM3' Cellsor CD3- Cells.
￿
PBMC were washed
twice in ice-cold PBS buffer (1% heat-inactivated human AB serum,
100 U/ml penicillin, and 100 hg/ml streptomycin in PBS) and in-
cubated for 30 min on ice with 2 p.l (per 106 PBMC) murine
anti-human LeuM3 (monocyte/macrophage antigen) or CD3 (T
cell antigen) mAb (Becton Dickinson & Co., Mountain View, CA).
PBMC were then washed and mixed with sheep anti-mouse
IgG-coated magnetic particles (Dynal, Oslo, Norway), at a ratio
ofthree beads per LeuM3' cell or six beads per CD3' cell. After
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cell suspension usingamagnetic particle concentrator (Dynal) . Frac-
tionated cells (5 x 106 cells/ml) were resuspended in RPMI and
incubated as described above.
Cytoj9uorometry Analysis. Unfractionated PBMC, LeuM3- ,
and CD3 - cells (0.5 x 106) were incubated first with murine
anti-human LeuM3 and CD3 mAbs, and then with FITC-
conjugated goat anti-human IgG (Tago Inc., Burlingame, CA).
Cells were then washed, fixed with 1% formaldehyde, and ana-
lyzed on a Epics 541 flow cytometer (Coulter Electronics, Hia-
leah, FL).
RNA Isolation and Northern Analysis .
￿
Preparation of total cel-
lular RNA and Northern blot analysis with a "P-labeled nucleic
acid probe were performed as described previously (6) . Theprobes
used were a 575-bp fragment of humanTNF-a cDNA (American
Type Culture Collection, Rockville, MD) anda full-length (2,000-
bp) chicken 0-actin cDNA subcloned -in pGEM3.
Results and Discussion
UnstimulatedPBMC did not synthesize detectable amounts
of TNF-at . LPS-stimulatedPBMC synthesized 8.41 ± 2 .05
ng/ml of TNF-a . Histamine itself did not induce TNF-a
synthesis (data not shown), but decreased the LPS-induced
synthesis of TNF-a (Fig. 1) . Suppression of cytokine syn-
thesis was observed at histamine concentrations from 10 -6
to 10-4M .
To determine whether the histamine-mediated decrease in
TNF-ca synthesis resulted from a direct effect of histamine
on LPS-stimulated monocytes, LeuM3+ cells were isolated
from PBMC . Unfractionated PBMC from five donors con-
tained 16.5 ± 1.2% LeuM3+ cells and 59.9 ± 3.2%MY
cells. After LeuM3+ selection, the LeuM3 - population con-
tained 2.7 ± 1.2% LeuM3+ cells and 73.5 ± 3.9% CD3+
cells . Unstimulated LeuM3+ cells did not synthesize detect-
able amounts of TNF-a . Histamine (10-5 M) reduced, to
a comparable extent, the LPS-induced synthesis of TNF-ca
by both LeuM3+ cells (62% inhibition, p < 0.05) and un-
fractionatedPBMC(79% inhibition, p< 0.05) (Fig. 2) . Since
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Figure 1 .
￿
Effect ofhistamine on the LPS-induced synthesis ofTNF-a .
PBMC were stimulated with LPS (10 ng/ml) in the absence (-) or pres-
ence of histamine (HIS ; 10-1° to 10-4 M) . Differences in TNF-a syn-
thesis were analyzed for significance by ANOVA (* * * = p < 0.001).
Data are expressed as mean *- SEM for five donors.
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Figure 2.
￿
Effect of histamine on the LPS-induced synthesis of TNF-a
in fractionatedPBMC . Unfractionated PBMC, LeuM34 cells, or CD3 -
cells were stimulated with LPS (10 ng/ml) in the absence (open ban) or
presence (stippled bars) ofhistamine (10-5 M) . Differences in TNF-a syn-
thesis within each cell population were analyzed for significance by Wil-
coxon signed-rank test (* = p<0.05) . Data are expressed as mean ±
SEM for five donors.
histamine activates T suppressor cells to release the histamine-
induced suppressor factor, which, in turn, could inhibit lym-
phokine production (1), CD3+ cells were removed from
PBMC, and CD3 - cells were then stimulated for TNF-a
synthesis. After CD3+ selection, the CD3 - population con-
tained 13.6 ± 3.2% LeuM3+ cells and 9.5 ± 1.4%MY
cells. Histamine (10-5 M) again reduced LPS-induced syn-
thesis ofTNF-a by CD3- cells (44% inhibition, p < 0.05)
(Fig . 2), indicating that the histamine-mediated decrease in
TNF-a synthesis by LPS-stimulated PBMC does not require
T cells .
Human monocytes, B cells, T helper cells, andT suppressor
cells express high affinity Ht receptors for histamine charac-
terized by akD in the nanomolar range (8) . PBMC have also
Figure 3.
￿
Effects of histamine receptor antagonists on the histamine-
mediated decrease in TNF-a synthesis . PBMC were preincubated with
diphenhydramine (10-5 M; hatched bars) or cimetidine (10-4 M; dotted
ban), or without drugs (open bars) . PBMC were then stimulated with LPS
(10 ng/ml) in the absence (-) or presence of histamine (HIS ; 10-5 M) .
Differences in TNF-a synthesis between drug-treated groups were ana-
lyzed for significance by ANOVA (» = p<0.05) . Differences in TNF-a
synthesis within drug-treated groups were analyzed for significance by
Student's t test for paired samples (** * = p<0.001) . Data are expressed
as mean ± SEM for five donors.Figure 4 .
￿
Dose-dependent effect ofcimetidine on the histamine-mediated
decrease in TNF-a synthesis . PBMC were preincubated with cimetidine
(CIM ; 10 -6 to 10-4 M), and then stimulated with LPS (10 ng/ml) in
the absence or presence of histamine (10-6M ; hatched ban; 10-5M; stip-
pled bars) . TNF-a levels from histamine-treated groups are expressed as
percentage of those from the corresponding control groups . Differences
in TNF-a synthesis between cimetidine-treated groups were analyzed for
significance byANOVA (* * = p < 0.01; * * * = p < 0.001) . Data are
expressed as mean ± SEM for three donors.
been shown to express low affinity H t receptors (9) as well
as H2 receptors for histamine (10), both characterized by a
kD in the micromolar range . PBMC were incubated in the
presence of diphenhydramine, an Hl receptor antagonist, or
cimetidine, an H2 receptor antagonist . Diphenhydramine
(10-5 M) or cimetidine (10 -4 M) alone did not induce syn-
thesis of TNF-a (n = 5, data not shown) . Diphenhydra-
mine modified neither LPS-induced TNF-a synthesis nor the
histamine (10-5 M)-mediated decrease in LPS-induced TNF-a
synthesis (Fig . 3), indicating that neither the high affinity
nor the low affinity H i receptor mediates the suppressive
effect of histamine on TNF-a synthesis . In contrast, cimeti-
dine reversed the histamine (10 -5 M)-mediated decrease in
LPS-induced synthesis ofTNF-a (Fig. 3) . Ranitidine, an H2
receptor antagonist structurally unrelated to cimetidine, also
reversed the histamine-mediated decrease in TNF-a synthesis
(data not shown) .
Cimetidine significantly enhanced LPS-induced synthesis
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of TNF-a (154% of LPS values, p < 0.05) (Fig. 3) in the
absence ofexogenous histamine . However, levels ofhistamine
in supernatants of unstimulated PBMC rose during 24 h of
incubation (0.4 ± 0.1 x 10-7 M before vs . 1.8 ± 0.3 x
10 -7M after incubation, p < 0.01, n = 4) . Histamine levels
in 24-h supernatants of LPS-stimulated PBMC (1.6 ± 0.4
x 10-7M) were not statistically different from those of un-
stimulated PBMC . These results suggest that endogenous
histamine production takes place in PBMC cultures and may
account for the increased synthesis ofTNF-a by cimetidine-
treated PBMC . In agreement with this hypothesis, macro-
phages and T lymphocytes synthesize histamine de novo
through induced histidine decarboxylase (11) .
Histamine reduces TNF-a synthesis in a competitive
manner, since cimetidine partially reversed the decrease in LPS-
induced synthesis ofTNF-a (12.93 ± 3.26 [untreated cells]
vs . 5 .05 ± 0.39 ng/ml [cimetidine-treated cells] ; p < 0.001,
n = 5) when histamine reached 10-4 M . The histamine-
mediated decrease in TNF-a synthesis was reversed by cimeti-
dine in a dose-dependent manner (Fig. 4) . Cimetidine (10-6
M) failed to reverse the histamine-mediated decrease in cytokine
synthesis, whereas higher concentrations of cimetidine (10 -5
and 10-4 M) partially or completely reversed the effect of
histamine 10 -6 or 10` 5 M .
Prostaglandin E2 suppresses multiple aspects of macro-
phage activation, including synthesis ofTNF-a (12) . Fur-
thermore, activation ofHl receptors leads to the generation
of arachidonic acid metabolites (13) . To determine whether
prostaglandin synthesis could account for the histamine-
mediated decrease in cytokine synthesis, PBMC were incubated
in presence of indomethacin, a cyclooxygenase inhibitor. In-
domethacin (1.3 x 10-6 M) itself did not induce synthesis
ofTNF-a (n = 5) . Indomethacin significantly enhanced LPS-
induced synthesis ofTNF-a (126% of LPS values, p < 0.05)
but did not modify the histamine (10-5 M)-mediated reduc-
tion in LPS-induced synthesis ofTNF-a (data not shown) .
Therefore, the histamine-mediated decrease in TNF-(x produc-
tion by LPS-stimulated PBMC does not require generation
ofprostaglandins . These results also support our observation
that triggering of Hl receptors does not contribute to the
suppressive effects of histamine on TNF-a synthesis.
Figure 5 . Effect of histamine on the LPS-induced
mRNA accumulation for TNF-a . PBMC were stimu-
lated by LPS (10 ng/ml) in the absence (-) or presence
of histamine (HIS ; 10-7 to 10 - 4 M) . mRNA levels for
TNF-a and ,Q-actin were analyzed 4 h after LPS stimula-
tionby Northern blotting (A) and dilutional analysis (B) .
(A) Levels of TNF-ct protein in the corresponding 4-h
PBMC cultures were assayed by RIA (upperpanel) . Total
RNA (10 pg) was subjected to electrophoresis in 6.6%
formaldehyde, 1.2% agarose gel, and transferred to nylon
membranes (Hybond-N; Amersham Corp ., Arlington
Heights, IL) by capillary blotting (lowerpanel) . Lower and
upper panels depict Northern blots and protein levels of
one experiment representative of three donors. (B) Serial
dilutions of total RNA (2.50, 1.25, 0.62, and 0.31 hg)
for an experiment representative of two donors are shown.Modulation by histamine ofmRNA levels and protein con-
centrations for TNF-a was studied 4 h after LPS stimula-
tion. Histamine itself did not induce mRNA accumulation
for TNF-a (data not shown). Histamine (10 -7 M) slightly
reduced LPS-induced synthesis of TNF-a protein, but did
not modify LPS-induced mRNA accumulation (Fig. 5).
Higher concentrations of histamine (10 -6 to 10-4 M)
markedly reduced TNF-a protein synthesis as well as TNF-a
mRNA accumulation (Fig. 5 A). Similar results were also
observed by dilutional analysis (Fig. 5 B) . Histamine (10 -6
to 10"4 M) reduced TNF-ca mRNA levels fourfold. The
histamine-mediated decrease in TNF-a synthesis is therefore
likely to be a transcriptional event, since the activation of
histamine H2 receptors results in generation of cAMP (14),
and increased levels of cAMP decrease the LPS-induced ac-
cumulation of TNF-ca mRNA in the macrophage cell line
RAW264, but have no effect on TNF-a mRNA stability
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